Keurig Dr Pepper price target lowered to $36 from $38 at UBS

UBS lowered the firm’s price target on Keurig Dr Pepper to $36 from $38 and keeps a Buy rating on the shares ahead of the Q4 earnings report on February 22. The set up heading into the report remains “tricky,” but thinks concerns on weaker organic growth are reflected in valuation and the risk/reward skews to the upside, the analyst tells investors in a research note.